# Cannabis Administration and Opportunity Act Summary
This comprehensive legislation decriminalizes cannabis at the federal level, removes it from the Controlled Substances Act schedule, and establishes federal regulation and taxation of cannabis products. The bill affects cannabis users, producers, retailers, and communities harmed by drug prohibition enforcement.
**Decriminalization and Legal Changes**
The bill removes marijuana from Schedule I of controlled substances within 180 days of enactment. Federal cannabis offense convictions are retroactively vacated and expunged, with individuals currently serving cannabis-only sentences to be released within 60 days. Pending charges must be dropped within 30 days. People may no longer be denied federal benefits, security clearances, or immigration benefits based on cannabis offenses.
**Taxation and Revenue**
A new federal excise tax on cannabis products starts at 10% and escalates to 25% by year five, with rates adjusted annually based on market prices. An "Opportunity Trust Fund" receives revenue from these taxes to fund restorative justice programs. Domestic cannabis manufacturers receive 50% tax credits during the initial phase.
**Federal Regulation and Licensing**
The FDA establishes a Center for Cannabis Products with authority to regulate safety, labeling, and product standards. Cannabis businesses require federal permits from the Treasury Department's Alcohol, Tobacco, and Cannabis Tax and Trade Bureau. The bill includes provisions for tracking cannabis products, preventing smuggling, and setting workplace safety standards.
**Restorative Justice and Community Reinvestment**
The legislation dedicates approximately $2.2 billion for programs benefiting communities and individuals harmed by cannabis prohibition, including $1.65 billion for community reinvestment grants (job training, legal aid, reentry services), $550 million for equitable cannabis licensing programs, and $17 million for small business loans to those adversely impacted by the War on Drugs.
**Research, Public Health, and Safety**
The bill funds $200 million annually through 2030 for biomedical cannabis research, $15 million annually for programs preventing underage cannabis use, and research on cannabis-impaired driving. It establishes a Cannabis Products Advisory Committee and requires studies on cannabis legalization's societal impact.
**State and Tribal Authority**
States, territories, and tribes may impose stricter cannabis regulations than federal law and maintain their own taxation. States